These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20553713)

  • 1. Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13.
    Nurmenniemi S; Kuvaja P; Lehtonen S; Tiuraniemi S; Alahuhta I; Mattila RK; Risteli J; Salo T; Selander KS; Nyberg P; Lehenkari P
    Exp Cell Res; 2010 Oct; 316(16):2676-82. PubMed ID: 20553713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
    Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
    Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.
    Brignole C; Marimpietri D; Di Paolo D; Perri P; Morandi F; Pastorino F; Zorzoli A; Pagnan G; Loi M; Caffa I; Erminio G; Haupt R; Gambini C; Pistoia V; Ponzoni M
    Cancer Res; 2010 Dec; 70(23):9816-26. PubMed ID: 20935225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
    Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
    Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
    Kauppila JH; Karttunen TJ; Saarnio J; Nyberg P; Salo T; Graves DE; Lehenkari PP; Selander KS
    APMIS; 2013 Jun; 121(6):511-22. PubMed ID: 23082743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
    Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
    Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell.
    Xu L; Wang C; Wen Z; Yao X; Liu Z; Li Q; Wu Z; Xu Z; Liang Y; Ren T
    Immunol Lett; 2010 Jan; 127(2):93-9. PubMed ID: 19854217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
    Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
    Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
    Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
    J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsins are required for Toll-like receptor 9 responses.
    Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
    Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
    Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M; Lee LN; Evans GF; Zuckerman SH
    J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.